Skip to main content
logo
Merdury Biopharmaceutical Corporation (TPEX:6932)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
4.960
-0.220 (-4.25%)
Jul 30, 2026, 1:55 PM CST

Merdury Biopharmaceutical Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-67.23-50.57-43.82-31.25-5.31
Depreciation & Amortization
11.647.454.072.750.97
Loss (Gain) From Sale of Assets
0.62----
Stock-Based Compensation
0.551.241.821.13-
Other Operating Activities
0.060.460.29-0.02-
Change in Accounts Receivable
0.01-0.01---
Change in Accounts Payable
1.622.570.644.860.9
Change in Unearned Revenue
0.315.040.44--
Change in Other Net Operating Assets
1.6-0.89-5.6-3.31-1.34
Operating Cash Flow
-50.84-34.71-42.15-25.84-4.78
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-6.88-10.02-12.93-68.51-6.98
Sale (Purchase) of Intangibles
-0.42-1.08-0.65-0.14-0.53
Investment in Securities
52.2121.98-176.08-108.7-
Other Investing Activities
-0.83-2.23-4.79-8.04-0.51
Investing Cash Flow
44.08108.65-194.44-185.4-8.02

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
---41.6-
Long-Term Debt Repaid
-4.16-1.45-1.07-0.99-0.39
Net Debt Issued (Repaid)
-4.16-1.45-1.0740.61-0.39
Issuance of Common Stock
4.527.1725020015.97
Repurchase of Common Stock
-8.56-56.24---
Other Financing Activities
-----0.3
Financing Cash Flow
-8.21-50.52248.93240.6115.28

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
0.130.290.01--
Net Cash Flow
-14.8423.7112.3629.382.48

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-57.72-44.73-55.07-94.35-11.77
Free Cash Flow Growth
-----
Free Cash Flow Margin
--901.17%-5331.17%-3520.60%-
Free Cash Flow Per Share
-0.14-0.11-0.14-0.25-0.04
Levered Free Cash Flow
-35.91-29.87-41.24-82.81-10.3
Unlevered Free Cash Flow
-35.35-29.37-40.8-82.56-10.3

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
0.90.80.710.40.01
Cash Income Tax Paid
0.070.340.210.02-
Change in Working Capital
3.536.71-4.511.56-0.45